US conditionally clears Integra/Codman Neuro after UK waves through

Integra LifeSciences has agreed to divest a range of healthcare product lines to nab US clearance for its acquisition of Johnson & Johnson’s neurosurgery medical products business – a deal already unconditionally cleared in the UK on the de minimis exception.

Get unlimited access to all Global Competition Review content